Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

The Bonnie J. Addario Lung Cancer Foundation Honors One of the World's Leading Lung Cancer Oncologists with the 2017 Addario Lectureship Award

Bonnie J. Addario Lung Cancer Foundation
Posted on: 29 Jul 17

Frances A. Shepherd, MD, FRCPC honored at the 18th International Lung Cancer Congress

SAN CARLOS, Calif., July 27, 2017 /PRNewswire-USNewswire/ -- The Bonnie J. Addario Lung Cancer Foundation (ALCF) will honor Frances A. Shepherd, M.D., FRCPC, with the  2017 Addario Lectureship Award for her leadership in improving treatment options and helping people with advanced lung cancer live longer. Dr. Shepherd received her M.D. from the University of Toronto and is currently a senior staff physician at Princess Margaret Cancer Centre and professor of medicine at the University of Toronto Faculty of Medicine. Dr. Shepherd will be the first woman to receive the award at the 18th International Lung Cancer Congress held July 27-29 in Huntington Beach, California.  

"Dr. Shepherd is instrumental in the lives of her patients, to the physicians across the world she has mentored and the field of lung cancer research and treatment," said Bonnie J. Addario, 13-year lung cancer survivor and founder of the ALCF. "Through her leadership, she has brought together a brilliant team of researchers committed treating lung cancer. Her team is one of the world leaders in bench to bedside research pertaining to lung cancer."

Dr. Shepherd is an Officer of the Order of Canada. She has mentored more than 30 post-doctoral research fellows from around the world, many of whom now hold senior academic positions in their home countries. Her major career accomplishments include:

Leading a clinical trial that resulted in chemotherapy following lung cancer surgery becoming the new standard of care around the world.

Heading a global trial that showed for the first time that a targeted therapy could prolong life for lung cancer patients who had no further options for treatment.

Creating NCIC trial-associated lung cancer tumor banks that contain both cancer and normal lung samples. These precious samples play a critical role in understanding the molecular abnormalities of lung cancer and help to identify patients who are most likely to benefit from specific therapies.

Dr. Shepherd is on the editorial board of several journals, including the Journal of Clinical Oncology. She has been lead or senior investigator in more than 100 clinical trials and authored more than 450 peer-reviewed publications. In 2005, she was the lead author of three articles published over a three-week period in the New England Journal of Medicine.

Dr. Shepherd is one of the world's leading lung cancer clinicians and researchers, known for her leadership in developing innovative therapies for lung cancer," said Addario. Dr. Shepherd has also established high quality lung tumor banks to support crucial trials necessary to conquer the world's deadliest cancer. "

Past Addario Lectureship Award recipients include:

2016-Giorgio Vittorio Scagliotti, M.D., Professor of Oncology, University of Torino, Head of the Department of Oncology and Chief of the Division of Medical Oncology, San Luigi Hospital, Torino, Italy

2015-Fred R. Hirsch, M.D., Ph.D., Professor of Medicine, University of Colorado School of Medicine

2014-Roy S. Herbst, M.D., Ph.D., Ensign Professor of Medicine and Chief of Medical Oncology, Yale Cancer Center

2013-Tony Mok, M.D., Professor in the Department of Clinical Oncology, Chinese University of Hong Kong in Prince of Wales Hospital in Hong Kong

2012-D. Ross Camidge, M.D., Ph.D., Director of the Thoracic Oncology Clinical Program and Associate Director for Clinical Research, Colorado University Cancer Center

2011-William Pao , M.D., Ph.D., Associate Professor of Medicine, Ingram Associate Professor of Cancer Research, Director, Personalized Cancer Medicine, Vanderbilt Ingram Cancer Center

2010-David R. Gandara , M.D., Associate Director, Clinical Research, UC Davis Cancer Center

2009-Harvey Pass , M.D., B.A., Director of the Division of Thoracic Surgery and Chief of Thoracic Surgery, New York University Medical Center

2008-Paul A. Bunn, Jr. M.D., Principal Investigator and Director, University of Colorado Cancer Center

The ALCF has supported the Lung Cancer Congress for the past ten years and serves as a co-sponsor, along with the International Association for the Study of Lung Cancer. The annual three-day event provides physicians with practical information about the clinical implications of lung cancer screening, the latest clinical data impacting the treatment of lung cancer and novel agents and strategies that are changing the future of lung cancer therapy.

About the Bonnie J. Addario Lung Cancer Foundation
The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest international philanthropies (patient-founded, patient-focused and patient-driven) devoted exclusively to eradicating lung cancer through research, early detection, education and treatment. The Foundation's goal is to work with a diverse group of physicians, organizations, industry partners, individuals, patients, survivors and their families to identify solutions and make timely and meaningful change and turn lung cancer into a chronically managed disease by 2023. The ALCF was established on March 1, 2006, as a 501c(3) non-profit organization and has raised more than $30 million for lung cancer research and related programs. For more information about the ALCF please visit www.lungcancerfoundation.org or follow us on Facebook or Twitter.

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 29/07/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.